Skip to main content

Home/ MaRS/ Group items tagged clinical

Rss Feed Group items tagged

Filter: All | Bookmarks | Topics Simple Middle
Karen Schulman Dupuis

CellAegis Devices Announces Initiation of Clinical Testing of Remote Ischemic... - 0 views

www.cellaegisdevices.com/...s%20Release%2011%2012%2012.pdf

clients lifesciences CellAegis_Devices

shared by Karen Schulman Dupuis on 28 Nov 12 - No Cached
  • Karen Schulman Dupuis on 28 Nov 12
     
    CellAegis Devices Announces Initiation of Clinical Testing of Remote Ischemic Conditioning (RIC) Using the autoRIC Device for Patients Undergoing Partial Nephrectomy
Assunta Krehl

MEDEC appoints Peter Robertson as Chair of the MEDEC Board of Directors - Digital Journ... - 0 views

www.digitaljournal.com/733343

shared by Assunta Krehl on 04 Jun 12 - No Cached
  • Assunta Krehl on 04 Jun 12
     
    "Peter Robertson as Chair of the MEDEC Board of Directors. Peter Robertson is Vice President and General Manager of GE Healthcare Canada. Peter is also a member of the management board for MaRS' Excellence in Clinical Innovation and Technology Evaluation (""EXCITE"") program."
Miguel Amante

Toronto's pharmaceutical biotech sector - Next Generation Pharmaceutical - June 2010 - 0 views

www.ngpharma.com/...toronto-pharmaceutical-biotech

life sciences biotechnology MaRS Innovation toronto health care

shared by Miguel Amante on 25 Jun 10 - Cached
  • Miguel Amante on 25 Jun 10
     
    Toronto is a globally competitive centre for groundbreaking basic and clinical research, with historical and current strengths in areas including new cancer therapeutics, stem cell research and development, genomics, bioinformatics, and the development of new diagnostic and therapeutic tools for every imaginable disease process.
Melissa Hughes

This Is What 'Instagram for Doctors' Looks Like - The Atlantic - June 12, 2013 - 0 views

www.theatlantic.com/...276792

Clients Figure1 entrepreneurship innovation

shared by Melissa Hughes on 13 Jun 13 - No Cached
  • Karen Schulman Dupuis on 13 Jun 13
     
    "Dr. Joshua Landy is envisioning a new way for doctors to learn from one another. A Toronto-based intensive care physician by trade, Landy is the co-founder of Figure 1, a "crowdsourced photo sharing app for health care professionals." Launched just two weeks ago, the iPhone app is already populated with images both clinically significant and arguably beautiful -- without even the benefit of a filter."
Assunta Krehl

Quest for a wonder drug started with shrew bait - The Globe and Mail - August 8, 2012 - 0 views

www.theglobeandmail.com/...article4470731

onocology Veronika Litinski life sciences clinical trials commericialization

shared by Assunta Krehl on 17 Aug 12 - No Cached
  • Assunta Krehl on 17 Aug 12
     
    "Jack Stewart a biotechnology entrepreneur, is about to start a human trial for a drug developed from a compound found in shrew spit that could treat ovarian, breast and prostate cancers without many of the side effects of chemotherapy." Veronika Litinski, a Senior Advisor at MaRS in the Life Science and Health care practice says it is difficult to run trials with a clear robust criteria.
Assunta Krehl

Science City - The Globe and Mail - 0 views

gold.globeinvestor.com/...APStory

MaRS McEwan Centre for Regenerative Medicine Ontario Institute for Cancer Research John Evans

shared by Assunta Krehl on 24 Aug 09 - Cached
  • This is Toronto's research district, a maze of concrete and glass where the finest minds collaborate, turning the city into a global centre of biomedical discovery.
  • Nine research institutes employing 5,000 university faculty members, 2,000 graduate students and 1,100 postdoctoral and clinical fellows lie within a 20-minute walk of each other. This biomedical cluster at the heart of Toronto is one of the largest on the continent, and is one of the 10 largest in the world.
  • Tom Hudson from Montreal; cell biologist Ben Neel from Boston; and stem-cell biologist Gordon Keller, who came to Toronto in 2006, just months after New York magazine named him one of the scientists that city could not afford to lose. Toronto is also home to Tak Mak, who discovered the "key to the immune system" T-cell receptor, and John Dick, who discovered the first cancer stem cell in 1994 and last year grew a human cancer in a lab mouse for the first time.
  • ...3 more annotations...
  • "There's an enthusiasm in the research community that's very exciting to be part of," says Dr. Keller, who now heads the McEwan Centre for Regenerative Medicine.
  • Dr. Hudson, who left Quebec to head the Ontario Institute for Cancer Research, says the city's "tremendous power" is built on a strong history: Stem-cell research began here. "It's innovative," he says of Toronto. "I've never felt closer in my research career to thinking we will have an impact. I feel my goals are going to happen here."
  • Still, John Evans, board chairman of the non-profit MaRS Centre, which helps to turn research into viable businesses, envisages a day when research is seen as a social and economic driver, and the city shines as brightly as better-known centres such as Boston and Palo Alto.
  • Assunta Krehl on 24 Aug 09
     
    Tenille Bonoguore, Globe and Mail features the MaRS Centre and meets 12 of its' "best specimens." MaRS is one of the 10 largest biomedical clusters in the continent.
  • Assunta Krehl on 24 Aug 09
     
    Tenille Bonoguore, Globe and Mail features the MaRS Centre and meets 12 of its' "best specimens." Bonoguore states "MaRS Centre is one of the 10 largest biomedical clusters in the continent." Jan 5, 2008
Assunta Krehl

Tiny particles expand frontier of medicine - The Star - February 27, 2010 - 1 views

www.healthzone.ca/...es-expand-frontier-of-medicine

life sciences biology MaRS Innovation MaRS

shared by Assunta Krehl on 01 Mar 10 - Cached
  • Assunta Krehl on 01 Mar 10
     
    Nanomedicine is a field that is growing and there will be an exponential growth in products. U of T scientists David Jaffray and Christine Allen are amongst those that are going through clinical trials. Allen and Jaffray's invention is being shephered to market by MaRS Innovation.
George Botos

Biotech, drug R&D grew in 2009 - Mass High Tech Business News - 1 views

www.masshightech.com/...tech-drug-RD-grew-in-2009.html

Life-Science biotech Investment

shared by George Botos on 18 Mar 10 - No Cached
  • Biotech, drug R&D grew in 2009
  • The R&D investments by PhRMA members and non-members in the pharmaceutical and biotech sectors reached a record $65.3 billion in 2009, an increase of 1.5 billion
  • there are more than 2,900 medicines in clinical trials or awaiting review
  • George Botos on 18 Mar 10
     
    The R&D investments by PhRMA members and non-members in the pharmaceutical and biotech sectors reached a record $65.3 billion in 2009, an increase of 1.5 billion despite the recession
1 - 12 of 12
Showing 20▼ items per page